Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Home/ Catalogue/ Neuroprotective/ TB-500 (Frag)
In stock
TB-500 (Frag)

TB-500 (Frag)

Lyophilised · ≥99% (HPLC) ·

Quantity Volume discounts auto-applied
Custom quantity
1
Shipping to EuropeDispatched from our EU facility in Slovakia, so EU destinations clear no third-country customs. Packeta, DPD or DHL Express depending on country — handling 1–2 business days, transit 2–7. Shipping is calculated at checkout and VAT is shown before you pay.

Supplied lyophilised. Reconstitution typically uses bacteriostatic water.

Independently third-party tested · COA on every batch · 48h EU dispatch
[01]

Overview

Hidden inside a large repair protein is a tiny fragment that the body cleaves out and uses on its own. TB-500 (Frag) is the synthetic acetylated tetrapeptide Ac-Ser-Asp-Lys-Pro (Ac-SDKP, also called goralatide), a naturally occurring fragment released from thymosin β4. Rather than the full thymosin β4 molecule, this listing is the short Ac-SDKP sequence itself — one of the most studied antifibrotic and anti-inflammatory peptide fragments in the literature.

A fragment with a life of its own. Ac-SDKP is generated endogenously from thymosin β4 through the action of prolyl oligopeptidase and is regulated within the renin-angiotensin system, where angiotensin-converting enzyme (ACE) is a primary route of its degradation (Kassem et al., 2019). Because ACE inhibition raises Ac-SDKP levels, the peptide sits at an intersection of cardiovascular and tissue-remodeling biology, making it a focused tool for fibrosis research distinct from full-length thymosin β4.

What the research explores. The literature concentrates on anti-fibrotic and anti-inflammatory endpoints:

  • Organ fibrosis — reviews describe the Tβ4-POP-Ac-SDKP axis and its role across fibrotic processes in multiple organs (Wang et al., 2022).
  • Pulmonary fibrosis models — a meta-analysis examined Ac-SDKP inhibition of pulmonary fibrosis in animal models (Gong et al., 2023).
  • ACE inhibition and hypertension — work synthesizes Ac-SDKP's role in ACE inhibition and its relevance to hypertension and tissue injury (Kumar et al., 2018).
  • Cardiovascular signaling — studies probe the relevance of the Tβ4-Ac-SDKP pathway to the cardiovascular system (Kassem et al., 2019).

These findings derive from in vitro and animal research describing biological activity; they do not establish safety or efficacy in humans. Full citations are listed under the Scientific References tab.

Physicochemical profile. CAS 120081-14-3 · Molecular formula C₂₀H₃₃N₅O₉ · Molecular weight 487.5 g/mol · Sequence Ac-Ser-Asp-Lys-Pro · Appearance: white lyophilized powder · Soluble in water.

Specification & quality. Each individually sealed vial contains 2 mg of TB-500 (Frag) — Ac-SDKP — as a white lyophilized powder at ≥99% purity by HPLC. Every batch is third-party tested, with a Certificate of Analysis (COA) available. Store at −20 °C, protected from light and moisture.

This product is intended for laboratory research use only (RUO). It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application. Handling is restricted to qualified research professionals operating in an appropriately equipped laboratory.

Supplied for in-vitro laboratory research use only (RUO). Not a drug, food or supplement; not for human or veterinary use.

[04]

Quality & COA

Certificate of Analysis
Lot-specific COA with every order

Certificate of Analysis — lot-specific COA ships with every order and is available on request.

Each lot is tested by an independent third-party laboratory for identity (mass spectrometry) and purity (HPLC). The Certificate of Analysis for your specific batch ships with the order and is available on request — no house data, no exceptions.

HPLC purity
≥99% (HPLC)
Method
HPLC + MS
Endotoxin
Reported
[02]

Data Sheet

CAS number120081-14-3
Molecular formulaC₂₀H₃₃N₅O₉
Molecular weight487.5
SequenceAc-Ser-Asp-Lys-Pro
Purity≥99% (HPLC)
Physical formWhite lyophilized powder
Quantity2mg/vial
SolubilitySoluble in water
StorageStore at -20°C, protect from light
Shelf life24 months from manufacture date
OriginEU · Slovakia
ClassificationResearch use only
[03]

Scientific References

01 Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026. PMID: 41966639. doi:10.1007/s40279-026-02437-0. PubMed 02 Mavrych V, Shypilova I, Bolgova O. Therapeutic peptides in gerontology: mechanisms and applications for healthy aging. Front Aging. 2026. PMID: 42021992. doi:10.3389/fragi.2026.1790247. PubMed 03 Rahman OF, Lee SJ, Seeds WA. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. J Am Acad Orthop Surg Glob Res Rev. 2026. PMID: 41490200. doi:10.5435/JAAOSGlobal-D-25-00236. PubMed 04 Di H, Huang J, Zhang D et al.. Thymosin beta 4: An emerging therapeutic candidate for kidney diseases. Peptides. 2026. PMID: 41570941. doi:10.1016/j.peptides.2026.171467. PubMed 05 Mayfield CK, Bolia IK, Feingold CL et al.. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. Am J Sports Med. 2026. PMID: 41476424. doi:10.1177/03635465251357593. PubMed 06 Gong HB, Zhang CM, Tang XY et al.. [Meta-analysis of Ac-SDKP inhibition of Pulmonary fibrosis in animal models]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2023. PMID: 37248179. doi:10.3760/cma.j.cn121094-20211115-00565. PubMed 07 Liu AD, Yang F. [Review on biological effects and mechanism of Ac-SDKP]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2023. PMID: 36882283. doi:10.3760/cma.j.cn121094-20220506-00238. PubMed 08 Wang W, Jia W, Zhang C. The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis. Int J Mol Sci. 2022. PMID: 36362069. doi:10.3390/ijms232113282. PubMed 09 Cantero-Navarro E, Fernández-Fernández B, Ramos AM et al.. Renin-angiotensin system and inflammation update. Mol Cell Endocrinol. 2021. PMID: 33798633. doi:10.1016/j.mce.2021.111254. PubMed 10 Naicker K, Ntsekhe M. Tuberculous pericardial disease: a focused update on diagnosis, therapy and prevention of complications. Cardiovasc Diagn Ther. 2020. PMID: 32420111. doi:10.21037/cdt.2019.09.20. PubMed 11 Kassem KM, Vaid S, Peng H et al.. Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system?. Can J Physiol Pharmacol. 2019. PMID: 30854877. doi:10.1139/cjpp-2018-0570. PubMed 12 Dadar M, Shahali Y, Chakraborty S et al.. Antiinflammatory peptides: current knowledge and promising prospects. Inflamm Res. 2019. PMID: 30560372. doi:10.1007/s00011-018-1208-x. PubMed 13 Ramasamy V, Mayosi BM, Sturrock ED et al.. Established and novel pathophysiological mechanisms of pericardial injury and constrictive pericarditis. World J Cardiol. 2018. PMID: 30344956. doi:10.4330/wjc.v10.i9.87. PubMed 14 Kumar N, Yin C. The anti-inflammatory peptide Ac-SDKP: Synthesis, role in ACE inhibition, and its therapeutic potential in hypertension and cardiovascular diseases. Pharmacol Res. 2018. PMID: 29990624. doi:10.1016/j.phrs.2018.07.006. PubMed 15 Vasilopoulou E, Riley PR, Long DA. Thymosin-β4: A key modifier of renal disease. Expert Opin Biol Ther. 2018. PMID: 29727205. doi:10.1080/14712598.2018.1473371. PubMed

References are illustrative of the research literature surrounding this compound. All claims relate to in-vitro and animal models only.

[05]

FAQ

TB-500 (Frag) is the synthetic tetrapeptide Ac-Ser-Asp-Lys-Pro (Ac-SDKP, also known as goralatide), a small fragment that the body cleaves from a larger thymosin β4 precursor and that acts on its own in research models. Condor Research supplies it as a 2 mg lyophilized vial at ≥99% HPLC purity, strictly for in-vitro laboratory research use only.

They are different molecules. TB-500 (Frag) is the four-residue Ac-SDKP (goralatide) tetrapeptide, whereas the standard TB-500 product is the much larger 43-residue actin-binding fragment derived from thymosin β4. The Frag isolates one short, naturally cleaved sequence rather than the full peptide. Condor Research offers each as a separate ≥99% HPLC, research-use-only reference compound, each with its own COA.

TB-500 (Frag) is the small Ac-SDKP tetrapeptide and is offered as a 2 mg vial, while the larger 43-residue TB-500 is supplied at 10 mg; the masses are analytical reference quantities for two distinct molecules, not doses. To compare value per mg or for current pricing, contact info@condorresearch.com. Both are ≥99% HPLC research-use-only materials.

TB-500 (Frag) isolates the single Ac-Ser-Asp-Lys-Pro (goralatide) sequence, a defined cleavage product, whereas full-length TB-500 is the 43-residue actin-binding fragment with broader structural features. Researchers choose the Frag to study that one short motif specifically. Both are supplied as separate ≥99% HPLC, research-use-only reference compounds; selection depends on your in-vitro research question.

TB-500 (Frag) is the Ac-SDKP tetrapeptide derived from thymosin β4 biology, while BPC-157 is a 15-residue gastric pentadecapeptide studied for cytoprotective mechanisms. They are both short peptides in regenerative research but have unrelated sequences and pathways. Condor Research offers each as a distinct ≥99% HPLC, research-use-only reference compound; the choice depends on your experimental target.

TB-500 (Frag) is selected when the focus is specifically the Ac-SDKP (goralatide) tetrapeptide as an isolated, naturally cleaved sequence, rather than the broader 43-residue thymosin β4 fragment. Researchers studying that short motif on its own choose the Frag. Both remain research-use-only reference materials with no human or veterinary application.

Yes. The acetylated tetrapeptide Ac-Ser-Asp-Lys-Pro (CAS 120081-14-3) is verified for each lot by an independent third-party laboratory using HPLC for purity and mass spectrometry for identity, confirming both the sequence and N-terminal acetylation. Results are documented on the batch-specific Certificate of Analysis, available on request at info@condorresearch.com.

Yes. TB-500 (Frag) is supplied strictly for laboratory research use only (in vitro). It is not a medicine, food, supplement, cosmetic, or medical device, and is not for human or veterinary use, administration, or consumption. Condor Research provides no dosing, protocols, or human-use guidance. Purchase is limited to qualified professionals and institutions aged 18 or over.

Yes. Each TB-500 (Frag) lot is tested by an independent third-party laboratory by HPLC for identity and purity, with mass spectrometry confirmation, and ships against a batch-specific Certificate of Analysis verifying ≥99% purity. To request the COA for the current lot before ordering, contact info@condorresearch.com.

For analytical laboratory preparation only, TB-500 (Frag) is water-soluble and can be reconstituted with a sterile aqueous diluent; with a 2 mg vial the chosen volume sets the working concentration. Store the sealed lyophilized vial at -20°C, protected from light, with a 24-month shelf life. This is laboratory handling information, not guidance for any human or animal use.

Condor Research supplies TB-500 (Frag) directly, dispatched from our EU facility in Slovakia to the EU, EEA, UK and Switzerland. Deliveries to EU destinations clear no third-country customs, and shipping is calculated at checkout. Supplied strictly as a research-use-only reference material — not for human or veterinary use.

[06]

Reviews

Leave a review
Earn 250 points for a verified review (account required).

No verified reviews yet.

Leave a review

Related compounds